Journal
CLINICAL & TRANSLATIONAL ONCOLOGY
Volume 20, Issue 1, Pages 22-28Publisher
SPRINGER INTERNATIONAL PUBLISHING AG
DOI: 10.1007/s12094-017-1763-6
Keywords
Glioblastoma; Treatment; Diagnosis; Guidelines
Categories
Ask authors/readers for more resources
Glioblastoma (GB) is the most common brain malignancy and accounts for over 50% of all high-grade gliomas. Radiotherapy (RT) with concomitant and adjuvant temozolomide (TMZ) chemotherapy is the current standard of care for patients with newly diagnosed GB up to age 70. Recently, a new standard of care has been adopted for elderly patients (65 years) based on short course of RT and TMZ. Several clinically relevant molecular markers that assist in diagnosis and prognosis have recently been identified. The treatment for recurrent GB is not well defined, and decision-making is usually based on prior strategies as well as several clinical and radiological factors. The presence of neurologic deficits and seizures can significantly impact quality of life.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available